Iceland vs South Africa: Access to anti-retroviral drugs, female
Iceland
86.0%
in 2024
South Africa
84.0%
in 2024
Iceland rank
47th
South Africa rank
50th
Access to anti-retroviral drugs, female over time
- Iceland
- South Africa
How they compare
Iceland currently reports 86.0% against 84.0% in South Africa, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Iceland ahead.
Iceland ranks 47th and South Africa ranks 50th of 141 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.4% | 6.1% | 57.3% | Iceland |
| 2010s | 84.0% | 54.6% | 29.4% | Iceland |
| 2020s | 83.6% | 81.8% | 1.8% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Iceland or South Africa?
- Iceland, at 86.0% against 84.0% in South Africa as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Iceland and South Africa?
- 2.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and South Africa?
- 25 years are reported by both, from 2000 to 2024.
- How do Iceland and South Africa rank globally for access to anti-retroviral drugs, female?
- Iceland ranks 47th and South Africa ranks 50th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.